| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/06/2005 | US20050004494 Lancet device having capillary action |
| 01/06/2005 | US20050004442 Measurement device for measuring electric signal emitted by biological sample |
| 01/06/2005 | US20050004356 Linker nucleoside, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004350 Novel chemiluminescent reagents |
| 01/06/2005 | US20050004349 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004324 Permselective structurally robust membrane material |
| 01/06/2005 | US20050004293 Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same |
| 01/06/2005 | US20050004178 Identification and use of lipid metabolism controllers; claimed knockout mouse, isolated EFA-hRUP25 polypeptide, recombinant vector and host cell; dyslipidemia, atherosclerosis, coronary heart disease, stroke, insulin resistance, type 2 diabetes |
| 01/06/2005 | US20050004078 Nucleotide analogs with six-membered rings |
| 01/06/2005 | US20050004068 Modulation of tor |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004040 Peptide having an affinity for gp120 |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004030 Degradation spores; infection therapy |
| 01/06/2005 | US20050004025 Modulation of acetylcholine receptors; central nervous system disorders; schizophenia; skin disorders; Alzheimer's and Parkinson's disease |
| 01/06/2005 | US20050004017 Antiproliferative agents; anticarcinogenic agents |
| 01/06/2005 | US20050004008 Determining metastatic of cancer using concentration of phosphorylated adaptor protein; anticancer agenst |
| 01/06/2005 | US20050004001 Diagnosis, prevention, therapy of autoimmune diseases, antiallergens, anticancer agents, antidiabetic agents |
| 01/06/2005 | US20050003997 Reduce body mass; obesity therapy; hyperlipemia; insulin resistance; atherosclerosis; antidiabetic agents; hypotensive agents |
| 01/06/2005 | US20050003560 Apparatus comprising immobilied antibodies for use in detection of preferential compounds in solution; biosensor |
| 01/06/2005 | US20050003559 Using paramagnetic particles comprising immobilized immunoglobulins as tools in separation of tumor cells from peripheral blood bone, marrow aspirates, ascities and other body fluids; immunodiagnostics and cancer diagnosis |
| 01/06/2005 | US20050003558 Biocompatibility; enhanced fractionations, enrichments, purifications, and expression product determinations; solid phase synthesis; kits; proteomics |
| 01/06/2005 | US20050003557 Method for immobilizing glycoproteins, constructs and apparatuses made thereby |
| 01/06/2005 | US20050003556 Probe Beads for affirnity reaction and detection system |
| 01/06/2005 | US20050003555 An integrated high throughput system for the analysis of biomolecules |
| 01/06/2005 | US20050003550 Analyzing device, e.g., a spectrophotometer, analyzes the physical properties of the dissolution liquid as the drug dosage dissolves; video monitoring, e.g., a stereo-microscope/video camera, records and correlates dissolving dosage images controlling temperature, flow rate and chemical parameters |
| 01/06/2005 | US20050003538 Double-transfected cell line useful for the identification of transport inhibitors |
| 01/06/2005 | US20050003529 Stem cells and method of separating the same |
| 01/06/2005 | US20050003527 Preparing prostate subpopulations via inoculating nutrient broth comprising collagen support matrix, estrogen and dihydrotestosterone with stromal tissues; for use as model systems for screening antiproliferative agents |
| 01/06/2005 | US20050003523 Test strip for determining concentration of multiple analytes in a single fluid sample |
| 01/06/2005 | US20050003522 Device for monitoring bodily fluids of mammals; specifically quality of milk from dairy cows |
| 01/06/2005 | US20050003519 Immunoassays, biochips; photolithography; solid phase synthesis |
| 01/06/2005 | US20050003517 Concentration measurement by sensing hydrogel pressure |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003509 Using chaperone protein activity to identify modulators for treatment and prevention of fungal growth; fungicides |
| 01/06/2005 | US20050003493 Kit comprising immunoblobulins which bind the bioactive, three-dimensional epitope of parathyroid hormone for use in classifying hypercalcemic disorders |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003489 Conformational and topological protein regulation |
| 01/06/2005 | US20050003483 Major histocompatibility complex peptide ligand for use in identifying modulators which prevent transplantation and autoimmunity disorders; immunotherapy |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003472 Process for the staining of sperm |
| 01/06/2005 | US20050003471 Methods of detecting megakaryocytes |
| 01/06/2005 | US20050003470 Glucose measuring device for use in personal area network |
| 01/06/2005 | US20050003468 Using immunodiagnostics to identify precancerous tissues; colorimetric analysis |
| 01/06/2005 | US20050003466 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050003465 Monoclonal abtibody specific to prostate cell-surface antigen associated with androgen-dependent and androgen-independent prostate tumors for use in prevention, diagnosis and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 01/06/2005 | US20050003464 Devices and methods to image objects |
| 01/06/2005 | US20050003463 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 01/06/2005 | US20050003462 Flow cytometry; immobilization; reduced background staining, enhanced peak signal separation between histograms obtained from cells stained with immunoglobulins; kits |
| 01/06/2005 | US20050003461 Determining allergenic sensitivity via monitoring concentration of mast and/or basophil cells in blood after exposure to interleukins; immunoassays |
| 01/06/2005 | US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders. |
| 01/06/2005 | US20050003459 Multi-purpose optical analysis disc for conducting assays and related methods for attaching capture agents |
| 01/06/2005 | US20050003458 Method and system for the analysis of high density cells samples |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003456 Method for separating hepatic progenitor cell |
| 01/06/2005 | US20050003455 Using myocardial cells and/or cultured vascular endothelial cells as tools in identifying modulators of chloride channel transport and treatments for cardiovascular disorders; antiapoptosis |
| 01/06/2005 | US20050003454 Conformational and topological protein regulation |
| 01/06/2005 | US20050003452 Fusion protein comprising membrane translocation sequences for use in identifying modulators for treatment and prevention of cell proliferative disorders |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003450 Immunoaffinity isolation of modified peptides from complex mixtures |
| 01/06/2005 | US20050003449 Fluorescent spectroscopy with 5-cyano-2-[(E)-2-(1-methyl-1H-indol-2-yl)ethenyl]benzoic acid as probe; high throughput assay |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003445 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003438 Conformational and topological protein regulation |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/06/2005 | US20050003430 Detecting polymers and polymer fragments |
| 01/06/2005 | US20050003429 Apparatus which utilizes changes in redox potential to detect preferential nucleic acids; identifying variation in nucleotide sequences using hybridization analysis |
| 01/06/2005 | US20050003426 Nucleotide sequences coding zinc finger protein comprising repeat sequences for use as tool in diagnosing and treating muscular disorders |
| 01/06/2005 | US20050003422 Determining response to administration of farnesyl transferase inhibitor such as (R)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone) by analyzing the presence or expression of oncogene; kits |
| 01/06/2005 | US20050003413 Using single chain immunoglobulin fragments as epitope anchors; for use as tool in monitor protein, lipids, sugars and metabolite levels and their modifications in single living cells; immunodiagnostics |
| 01/06/2005 | US20050003408 Libraries of oligomers labeled with different tags |
| 01/06/2005 | US20050003406 Using expression pattern of notch signaling pathway protein (JAG2) as diagnostic indicator of cell proliferative disorders |
| 01/06/2005 | US20050003405 Using g protein coupled receptors expression as diagnostic/prognostic indicator of cell proliferative disorders; immunotherapy |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003398 Target analyte detection using asymmetrical self-assembled monolayers |
| 01/06/2005 | US20050003396 Biosensors having single reactant components immobilized over single electrodes and methods of making and using thereof |
| 01/06/2005 | US20050003393 Using differential gene expression in neuronal cells to identify and monitor efficacy of psychotropic medications |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003390 Targets for controlling cellular growth and for diagnostic methods |
| 01/06/2005 | US20050003389 Computationally targeted evolutionary design |
| 01/06/2005 | US20050003387 Using tumor necrosis factor-related apoptosis-inducing ligand as a tool to identify modulators of programmed cell death for use in treatment of cell proliferative disorders |
| 01/06/2005 | US20050003376 Single molecule detection with surface-enhanced raman scattering and applications in DNA or RNA sequencing |
| 01/06/2005 | US20050003375 Stable isotope metabolic labeling for analysis of biopolymers |
| 01/06/2005 | US20050003373 An integrated high throughput system for the analysis of biomolecules |
| 01/06/2005 | US20050003372 An integrated high throughput system for the analysis of biomolecules |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003368 Cancer monitoring and therapeutics |
| 01/06/2005 | US20050003362 Determining the kinetic parameters of a complex formed between two components; monitoring ligand/receptor interaction; drug screening |
| 01/06/2005 | US20050003361 Method and kit for proximity probing with multivalent proximity probes |
| 01/06/2005 | US20050003360 Using matrix comprising immobilized antibodies complexde with DNA-conjugated antibodies to isolate preferential proteins in solution; biosensors for detecting proteins, modified-proteins, protein-protein interactions, protein-DNA interactions, autoantibodies and protein-small molecule interactions |
| 01/06/2005 | US20050003358 Novel cancer marker and uses therefor in the diagnosis of cancer |
| 01/06/2005 | US20050003356 Using presence of polymorphism in chaperonin gene sequences to predict coronary artery and atherosclerotic diseases |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050003351 Non-invasive prenatal genetic diagnosis using transcervical cells |